Phase 2 Readout~quarter

Phase 2 Readout: intranasal foralumab

Indication
non-active Secondary Progressive Multiple Sclerosis

Other upcoming events for TLSA

Phase 2 ReadoutPhase 2 Readout: intranasal foralumab

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: intranasal foralumab — TLSA Phase 2 Readout | BioSniper